Lewis Clayton Cantley Jr., Director at AGIOS PHARMACEUTICALS INC (AGIO), sold 2,715 shares at $57.90 ($160K) on 2017-12-06, disclosed to the SEC on 2017-12-08.
Scheduled sale ($160k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.90 | 542 | $31K | 19.6% |
| 2 | $57.90 | 543 | $31K | 19.6% |
| 3 | $58.95 | 254 | $15K | 9.3% |
| 4 | $58.95 | 253 | $15K | 9.3% |
| 5 | $60.01 | 204 | $12K | 7.6% |
| 6 | $59.68 | 288 |
| $17K |
| 10.7% |
| 7 | $60.45 | 631 | $38K | 23.8% |
| Total | $59.04 avg | 2,715 | $160K | 100% |
| Filing → |
| AGIO | SELL | 2017-09-15 | $131K | — | Filing → |
| AGIO | SELL | 2017-08-24 | $114K | — | Filing → |
| AGIO | SELL | 2017-07-21 | $254K | — | Filing → |